P

Inventor

BANVILLE JACQUES

CA28 patents
⚠️ This page may combine multiple inventors who share the name “BANVILLE JACQUES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

25 patents
US5663151ASep 2, 1997

Sulfated α-glycolipid derivatives as cell adhesion inhibitors

BRISTOL MYERS SQUIBB CO68 citations96
US7192948B2Mar 20, 2007

Bicyclic heterocycles as HIV integrase inhibitors

BRISTOL MYERS SQUIBB CO34 citations92
US7176196B2Feb 13, 2007

Bicyclic heterocycles as HIV integrase inhibitors

BRISTOL MYERS SQUIBB CO35 citations92
US7173022B2Feb 6, 2007

Bicyclic heterocycles as HIV integrase inhibitors

BRISTOL MYERS SQUIBB CO31 citations92
US7157447B2Jan 2, 2007

Bicyclic heterocycles as HIV integrase inhibitors

BRISTOL MYERS SQUIBB CO30 citations92
US6414179B1Jul 2, 2002

Alpha-and beta-substituted trifluoromethyl ketones as phospholipase inhibitors

BRISTOL MYERS SQUIBB CO32 citations92
US6350892B1Feb 26, 2002

Trifluoromethyl ketone analogs as selective cPLA2 inhibitors

BRISTOL MYERS SQUIBB CO41 citations92
US7109186B2Sep 19, 2006

HIV integrase inhibitors

BRISTOL MYERS SQUIBB CO27 citations91
US9688695B2Jun 27, 2017

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO11 citations90
US6777440B2Aug 17, 2004

HIV integrase inhibitors

BRISTOL MYERS SQUIBB CO14 citations84
US10822343B2Nov 3, 2020

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO4 citations83
US10428077B2Oct 1, 2019

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO8 citations83
US10047103B2Aug 14, 2018

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO11 citations83
US7494984B2Feb 24, 2009

Substituted imidazo[1,2-a]pyrimidines as HIV viral DNA integrase inhibitors

BRISTOL MYERS SQUIBB CO8 citations83
US6255496B1Jul 3, 2001

Trifluoromethyl ketone analogs as selective cPLA2 inhibitors

BRISTOL MYERS SQUIBB CO15 citations83
US7511037B2Mar 31, 2009

N-[[4-fluoro-2-(5-methy-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4-,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitor

BRISTOL MYERS SQUIBB CO7 citations73
US6890942B2May 10, 2005

Acyl sulfonamides as inhibitors of HIV integrase

BRISTOL MYERS SQUIBB CO9 citations72
US6803378B2Oct 12, 2004

HIV integrase inhibitors

BRISTOL MYERS SQUIBB CO6 citations72
US9862730B2Jan 9, 2018

Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO5 citations70
US5565433AOct 15, 1996

Sulfated β-glycolipid derivatives as cell adhesion inhibitors

BRISTOL MYERS SQUIBB CO5 citations63
US8039458B2Oct 18, 2011

HIV integrase inhibitors

BRISTOL MYERS SQUIBB CO2 citations62
US7893055B2Feb 22, 2011

HIV integrase inhibitors

BRISTOL MYERS SQUIBB CO4 citations61
US6924391B2Aug 2, 2005

Alpha-amino,-thio,-oxo substituted ketones as phospholipase inhibitors

BRISTOL MYERS SQUIBB CO2 citations61
US12084452B2Sep 10, 2024

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO0 citations60
US6492550B2Dec 10, 2002

Alpha-substituted thio, -oxo trifluoromethylketones as phospholipase inhibitors

BRISTOL MYERS SQUIBB CO1 citations51

UNIV MONTREAL

3 patents